Search
Author
- Anas A., Rana (1)
- Rainer, Doffinger (1)
- Syed M. T., Nasser (1)
Subject
Date issued
- 2023 (1)
Has File(s)
- true (1)
Search Results
Divergence between deterioration to life-threatening COVID-19 or clinical improvement occurs for most within the first 14 days of symptoms. Life-threatening COVID-19 shares clinical similarities with Macrophage Activation Syndrome, which can be driven by elevated Free Interleukin-18 (IL-18) due to failure of negative-feedback release of IL-18 binding protein (IL-18bp). We, therefore, designed a prospective, longitudinal cohort study to examine IL-18 negative-feedback control in relation to COVID-19 severity and mortality from symptom day 15 onwards. |